ARTICLE | Company News
Cymbalta approved for chronic musculoskeletal pain
November 5, 2010 11:19 PM UTC
FDA approved an sNDA from Eli Lilly and Co. (NYSE:LLY) to expand the label of Cymbalta duloxetine to include the treatment of chronic musculoskeletal pain. In August an FDA advisory committee voted 8-...